Malaysia - Tiếng Anh - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

era herbal products sdn. bhd. - lygodium japonicum; sargentodoxa cuneata; taraxacum mongolicum; paeonia suffruticosa; polygonum cuspidatum; rehmannia glutinosa; cornus officinalis; dioscorea opposita; poria cocos; alisma plantago-aquatica; astragalus mongholicus; leonurus heterophyllus -

Malaysia - Tiếng Anh - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

tong jum chew (m) sdn. bhd. - lycopodium japonicum; dioscorea hypoglauca; sargentodoxa cuneata; alisma orientale; coix lacryma-jobi; smilax glabra; panax notoginseng; salvia miltiorrhiza; achyranthes bidentata; angelica pubescens -

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

kinhong (pte) limited - granules (internal use)

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

kinhong healthcare manufacturing pte. ltd. - granules (internal use)

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

purapharm international (singapore) pte ltd - granules (internal use)

Israel - Tiếng Anh - Ministry of Health

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone as acetate - film coated tablets - estradiol as hemihydrate 1 mg; norethisterone as acetate 0.5 mg - norethisterone and estrogen - norethisterone and estrogen - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in women more than one year after menopause. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of , or contraindicated for, other medicinal products approved for the prevention of osteoporosis. the experience treating women older than 65 years is limited.

Israel - Tiếng Anh - Ministry of Health

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone acetate - film coated tablets - estradiol as hemihydrate 0.5 mg; norethisterone acetate 0.1 mg - estradiol, combinations - estradiol, combinations - eviana is indicated for women who have a uterus for the: treatment of moderate to severe vasomotor symptoms associated with menopause. prevention of postmenopausal osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered .the experience treating women older than 65 years is limited .

Úc - Tiếng Anh - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim pty limited, vetmedica division - medroxyprogesterone acetate - endocrine system - cat | dog - female (bitch) | horse mare (female) | bitch | castrate | cat - queen | cat - tom | female horse | kitten - sex hormones | abortion | anoestrus | controlled breeding | luteolytic agent | oestrus control | oestrus induction

Israel - Tiếng Anh - Ministry of Health

organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - vaginal ring - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.

Israel - Tiếng Anh - Ministry of Health

merck serono ltd - follitropin alfa - powder for solution for injection - follitropin alfa 5.5 mcg/dose - follitropin alfa - follitropin alfa - 1) gonal-f followed by chorionic gonadotrophin (hcg) is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf) gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism.